Thieme E-Books & E-Journals -
Thorac Cardiovasc Surg 2024; 72(S 01): S1-S68
DOI: 10.1055/s-0044-1780639
Monday, 19 February
Disclaimer

Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure (BioVAT-DZHK20): Trial Design and Experience at UKSH Lübeck

Authors

  • S. Ensminger

    1   Clinic for Heart and Thoracic Vessel Surgery, Lübeck, Deutschland
  • B. Fujita

    2   Lübeck, Deutschland
  • A. Aboud

    3   University Hospital of Schleswig-Holstein, Luebeck Campus, Lübeck, Deutschland
  • C. Paitazoglou

    3   University Hospital of Schleswig-Holstein, Luebeck Campus, Lübeck, Deutschland
  • I. Eitel

    3   University Hospital of Schleswig-Holstein, Luebeck Campus, Lübeck, Deutschland
  • D. Jurczyk

    4   University Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Deutschland
  • M. Mezger

    4   University Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Deutschland
  • F. Yebran

    5   University Medical Center Göttingen, Göttingen, Deutschland
  • I. Kutschka

    5   University Medical Center Göttingen, Göttingen, Deutschland
  • M. Tiburcy

    5   University Medical Center Göttingen, Göttingen, Deutschland
  • T. Legler

    5   University Medical Center Göttingen, Göttingen, Deutschland
  • J. Riggert

    5   University Medical Center Göttingen, Göttingen, Deutschland
  • M. Placzek

    5   University Medical Center Göttingen, Göttingen, Deutschland
  • T. Friede

    5   University Medical Center Göttingen, Göttingen, Deutschland
  • A.F. Jebran

    6   Göttingen, Deutschland
  • T. Seidler

    5   University Medical Center Göttingen, Göttingen, Deutschland
  • W.H. Zimmermann

    5   University Medical Center Göttingen, Göttingen, Deutschland